Cyberounds Logo
August 23, 2019 | LOGIN | REGISTER | HELP | 
email a friend print Bookmark and Share
Hyperthyroidism in Pregnancy
CME credit is no longer available for this conference.

Tricia Westhoff, M.D., and Eli Ipp, M.D.

Dr. Westhoff is Endocrinology Fellow, Harbor-UCLA Medical Center and Dr. Ipp is Professor of Medicine, UCLA School of Medicine.

Dr. Westhoff reports no commercial conflict of interest. In the past three years, Dr. Ipp has received grant/research support from Pfizer, Inc., R.W. Johnson, and Novo-Nordisk. He has served as a consultant for Novo-Nordisk, SmithKline Beecham Pharmaceutical and Hoechst Marion Roussel. Dr Ipp has also served on the Speakers' Bureau for Novo-Nordisk.


Release Date: 09/01/2001
Termination Date: 09/01/2004

Estimated time to complete: 1 hour(s).

Albert Einstein College of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
 
Learning Objectives
Upon completion of this Cyberounds®, you should be able to:
  • Describe mechanisms for hyperthyroidism in pregnancy
  • Discuss the principles of treatment of hyperthyroidism in pregnancy and breast-feeding
  • Discuss the impact of hyperthyroidism on the fetus and neonate.

 
This conference may include discussion of commercial products and services.

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
 
Please click below to accept the terms of this CME activity